Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A review of biological targets and therapeutic approaches in the management of triple-negative breast cancer
Hitesh Kumar, Neha Gupta, Rupshee Jain, et al.
Journal of Advanced Research (2023) Vol. 54, pp. 271-292
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Recent advances in targeted strategies for triple-negative breast cancer
Shuangli Zhu, Yuze Wu, Bin Song, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 113
Predictive, preventive, and personalized medicine in breast cancer: targeting the PI3K pathway
Muhammad Tufail, Jia-Ju Hu, Jie Liang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 25
Targeting triple negative breast cancer stem cells using nanocarriers
Nagasen Dasari, Girijasankar Guntuku, Sai Kiran S. S. Pindiprolu
Discover Nano (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 17
PIWI-interacting RNA-YBX1 inhibits proliferation and metastasis by the MAPK signaling pathway via YBX1 in triple-negative breast cancer
Linyu Wu, Shanshan Huang, W. H. Tian, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 15
Recent trends and advances in novel formulations as an armament in Bcl-2/Bax targeted breast cancer
Shaikh Samia, Padakanti Sandeep Chary, Omar M. Khan, et al.
International Journal of Pharmaceutics (2024) Vol. 653, pp. 123889-123889
Closed Access | Times Cited: 15
METTL1-mediated tRNA m7G methylation and translational dysfunction restricts breast cancer tumorigenesis by fueling cell cycle blockade
Dan Du, Mingxia Zhou, Chenxi Ju, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 9
Co-delivery of fucoxanthin and Twist siRNA using hydroxyethyl starch-cholesterol self-assembled polymer nanoparticles for triple-negative breast cancer synergistic therapy
Zeliang Wu, Yuxiang Tang, Yuanhui Liu, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 8
Shikonin blocks CAF-induced TNBC metastasis by suppressing mitochondrial biogenesis through GSK-3β/NEDD4-1 mediated phosphorylation-dependent degradation of PGC-1α
Shuangqin Fan, Xiaomin Yan, Xiaoxia Hu, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 7
Molecular Changes in Breast Cancer Induced by Radiation Therapy
Kim Sheva, Sangita Roy Chowdhury, Nataly Kravchenko‐Balasha, et al.
International Journal of Radiation Oncology*Biology*Physics (2024) Vol. 120, Iss. 2, pp. 465-481
Closed Access | Times Cited: 5
Next-generation biomarkers for prognostic and potential therapeutic enhancement in Triple negative breast cancer
Risav Banerjee, Indrajit Maitra, T. Bhattacharya, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 201, pp. 104417-104417
Closed Access | Times Cited: 5
Gold Nanobiosensors: Pioneering Breakthroughs in Precision Breast Cancer Detection
Soheil Sadr, Ashkan Hajjafari, Abbas Rahdar, et al.
European Journal of Medicinal Chemistry Reports (2024), pp. 100238-100238
Open Access | Times Cited: 4
Prodelphinidin from Purple Sweet Potato Induces Apoptosis in Human Triple-Negative Breast Cancer Cells via Reactive Oxygen Species and Endoplasmic Reticulum Stress Through the Mitochondrial Apoptosis Pathways
Jie Zhang, Zihan Chen, Shibo Wang, et al.
Research Square (Research Square) (2025)
Open Access
Targeting HSP90AA1 to overcome multiple drug resistance in breast cancer using magnetic nanoparticles loaded with salicylic acid
Ou Chen, Linlin Fu, Yu Wang, et al.
International Journal of Biological Macromolecules (2025) Vol. 298, pp. 139443-139443
Closed Access
A review of the current status of biological effects of plant-derived therapeutics in breast cancer
Shantanu Pachal, Hitesh Kumar, Rupshee Jain, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
In situ generation of Copper sulfide within Poly(lactic-co-glycolic acid): A strategy for Safer photothermal therapy in Triple-Negative breast cancer
Zhenzhen Chen, Li Hu, Bingbing Xu, et al.
International Journal of Pharmaceutics (2025), pp. 125287-125287
Closed Access
Comprehensive characterization of fatty acid oxidation in triple-negative breast cancer: Focus on biological roles and drug modulation
Yunduo Liu, Yanxia Zhang, Qin Xiang, et al.
European Journal of Pharmacology (2025), pp. 177343-177343
Closed Access
Discovery of a Novel Selective and Cell-Active N6-Methyladenosine RNA Demethylase ALKBH5 Inhibitor
Xianyuan Yang, K. X. Huang, Xu-Nian Wu, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
An update on cancer stem cell survival pathways involved in chemoresistance in triple-negative breast cancer
Asma Jan, Shazia Sofi, Nusrat Jan, et al.
Future Oncology (2025), pp. 1-21
Closed Access
2-(Diarylalkyl)Aminobenzothiazole Derivatives Induce Autophagy And Apoptotic Death Through SIRT Inhibition And P53 Activation In MCF7 Breast Cancer Cells
Kojja Venkateswarlu, V. Dinesh Kumar, Praveen Kumar Kalavagunta, et al.
Computational Biology and Chemistry (2025) Vol. 116, pp. 108395-108395
Closed Access
Prodelphinidin from purple sweet potato induces apoptosis in human triple-negative breast cancer cells via ROS-mediated ER stress activation
Jie Zhang, Zihan Chen, Shibo Wang, et al.
Medical Oncology (2025) Vol. 42, Iss. 4
Closed Access
The RNA-binding protein LARP6 regulates the alternative splicing of related genes in MDA-MB-231 cells
Li Guo, Yaobang Liu, Shuxun Yan, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Prediction of neoadjuvant chemotherapy efficacy and prognostic biomarker analysis in patients with triple-negative breast cancer
Xiao-Wen Liao, Jie Gao, Hong Sun, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Musashi inhibitor Ro 08–2750 attenuates triple-negative breast cancer cell proliferation and migration and acts as a novel chemo- and radiosensitizer
Kathrin A. Brücksken, Mark Sicking, Eberhard Korsching, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 186, pp. 118002-118002
Closed Access
CircATP5C1 promotes triple-negative breast cancer progression by binding IGF2BP2 to modulate CSF-1 secretion
Hongbo Liu, Haoqi Wang, Wei Gao, et al.
Cancer Biology & Therapy (2025) Vol. 26, Iss. 1
Open Access
A comprehensive review on targeted therapies for triple negative breast cancer: an evidence-based treatment guideline
Hosny I. Emara, Nageh K. Allam, R.A. Youness
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top